Bligh James 4
4 · CONDUIT PHARMACEUTICALS INC. · Filed Dec 5, 2023
Insider Transaction Report
Form 4
Bligh James
DirectorCFO
Transactions
- Award
Stock Option (Right to Buy)
2023-12-01$5.51/sh+223,634$1,232,223→ 223,634 totalExercise: $5.51Exp: 2033-11-30→ Common Stock (223,634 underlying)
Footnotes (2)
- [F1]Represents Options to purchase common stock, granted under the Company's 2023 Stock Incentive Plan.
- [F2]The stock options were granted with a ten-year term and vest 25% on each of the first four anniversaries of the vesting commencement date, which is September 22, 2023.